A prediction rule to identify low-risk patients with community-acquired pneumonia
about
Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumoniaDemographics, guidelines, and clinical experience in severe community-acquired pneumoniaCommunity acquired bacterial pneumoniaPneumonia: update on diagnosis and managementPrior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumoniaHow to handle mortality when investigating length of hospital stay and time to clinical stabilityEmpiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adultsProcalcitonin to initiate or withhold antibiotics in acute respiratory tract infectionsEmpiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adultsGranulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adultsGranulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adultsRespiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trialsBTS Guidelines for the Management of Community Acquired Pneumonia in AdultsDefining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyRacial variations in processes of care for patients with community-acquired pneumoniaDeterminants for hospitalization in " low-risk" community acquired pneumoniaThe effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.Assessing, treating and preventing community acquired pneumonia in older adults: findings from a community-wide survey of emergency room and family physicians.The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumoniaBench-to-bedside review: outcome predictions for critically ill patients in the emergency department.Severe community-acquired pneumonia: timely management measures in the first 24 hoursBeta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: A systematic review and meta-analysisA clinical perspective of sepsis-associated deliriumAdvances in the prevention, management, and treatment of community-acquired pneumoniaPrognostic value of procalcitonin in pneumonia: A systematic review and meta-analysisSystematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infectionsPneumonia, thrombosis and vascular diseaseClinical prediction rules in practice: review of clinical guidelines and survey of GPsNew aspects in the management of pneumoniaOutcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortalityGuidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionAcute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypesClinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials GroupBacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of careEpidemiology and management of common pulmonary diseases in older personsMicrobiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in KoreaThe best of respiratory infections from the 2015 European Respiratory Society International CongressThe Use of Guidelines for Lower Respiratory Tract Infections in Tanzania: A Lesson from Kilimanjaro CliniciansElevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deathsThe threat and prospects for control of an influenza pandemic.
P2860
Q21194921-DB10B990-B20D-4E94-9150-F1F433B72BC7Q21195015-02AC9319-61BD-4731-AF27-96561FED4EA2Q22241379-B35050A3-EDAF-443C-98A4-4E5967A258FAQ22242097-9EB23BBA-C4FF-4022-9D98-66A097AA5A4BQ23911823-CE243557-D64A-44A7-808F-00F71C5EF429Q23913313-4D212F52-8177-4908-8DDC-C1B03A4E1859Q24200609-7F5335F8-BDCB-44B4-A8C3-5771B8A439DAQ24241768-B2E570EB-0954-4595-B0D9-0742BA27282FQ24242728-EDCBE452-653E-4EB7-9956-47BBA4099567Q24245539-EC67DB5A-4577-400B-BD57-A124FB0B9F0CQ24246628-3157887B-307E-4D9D-8FC7-28B2D1D9BABBQ24655866-8C68654A-945E-48BF-A1A6-26E5D844F1B1Q24675547-6A2CF017-61CA-4EDA-92D0-FCD879A6371FQ24678793-CAD4AC7F-1E9B-4AB2-A620-9ED085F403B1Q24803541-8AD52CA8-46E2-4663-9812-B847D69A0E82Q24806482-F9FA856D-4B64-482F-90A1-C6117A59F779Q24811721-6D4ABA15-BF79-4E34-8B48-955624F20A5AQ24811893-DA756620-BEB0-448F-9A9A-61298AFF3E47Q24816802-33E04DA1-0925-454C-8424-59F7A4A48AA4Q24817051-D3C67FA7-D726-469C-825E-7DB28DE62B7EQ26738591-DC6C6511-DD45-4D5C-B250-FAB0781246E8Q26747529-42461CAC-3F41-4371-84A5-4AA88DF97900Q26751613-9F162B6E-2A22-4182-9DF1-C682CECF7BE1Q26753138-B3AE2008-52A6-4BDE-871B-7AB01DB35345Q26776356-03373424-6F67-49DE-83B6-357BBDE6FB6AQ26782662-FC7F8144-AD4C-46C9-AE71-CED43FCE57A7Q26853685-73AB393F-93CB-4E49-8786-F1BF068A72AFQ27002373-E8E33CDB-CE1B-4358-AE64-8D3C30E1F452Q28080025-F7D4DDAD-340C-48FA-AAC5-F61CE573925BQ28141559-B95B83E2-DB5E-447D-B89C-8EB21C0C92A1Q28201389-1B14F001-2F8B-4B4F-812F-F8E85645C249Q28244801-C2D3F317-6624-48EB-9FE3-D251DCEC672EQ28344357-AF2FB6D9-7D33-4DAB-8D10-174F63D73883Q28386764-357CB6AA-7C6E-4AA6-AAFF-C7795D0B3F21Q28397465-6C4FC46E-AC27-4D77-A3CA-F812C237B709Q28553554-8E9FEDE4-EAF1-4009-9CC5-7F39045C8FA6Q28598393-D9F8C3E1-2AAB-4936-BD72-F504577BF91EQ28602828-D6681068-E312-4796-89D2-1E0666373BDBQ28741566-4B8EA4C5-E43C-46A6-96A1-1A7E6D918C38Q30233313-5A1C2089-0053-49D2-8933-81B83D6009F3
P2860
A prediction rule to identify low-risk patients with community-acquired pneumonia
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A prediction rule to identify low-risk patients with community-acquired pneumonia
@ast
A prediction rule to identify low-risk patients with community-acquired pneumonia
@en
A prediction rule to identify low-risk patients with community-acquired pneumonia
@nl
type
label
A prediction rule to identify low-risk patients with community-acquired pneumonia
@ast
A prediction rule to identify low-risk patients with community-acquired pneumonia
@en
A prediction rule to identify low-risk patients with community-acquired pneumonia
@nl
prefLabel
A prediction rule to identify low-risk patients with community-acquired pneumonia
@ast
A prediction rule to identify low-risk patients with community-acquired pneumonia
@en
A prediction rule to identify low-risk patients with community-acquired pneumonia
@nl
P2093
P3181
P1476
A prediction rule to identify low-risk patients with community-acquired pneumonia
@en
P2093
B H Hanusa
D E Singer
L A Weissfeld
T J Marrie
W N Kapoor
P304
P3181
P356
10.1056/NEJM199701233360402
P407
P577
1997-01-23T00:00:00Z